Published trade mark details for 2189117
This information was published on 2021-07-02T07:27:15 for IP Right Acceptance Published.
| Field | Value |
| (210) | 2189117 (IR 1598873) |
| (220) |
10 Apr 2021
|
| (300) |
DE, 16 Oct 2020, 30 2020 022 626
|
| (500) |
Blue and green.
Blue and green. The applicant has advised that the words in the Mark have no meaning in English |
| (511) (510) |
Class 1
Stem cells for scientific or research use; cell growth media for growing cells for scientific use. Class 5 Pharmaceutical drugs; pharmaceutical and veterinary preparations; pharmaceutical preparations; diagnostic agents for medical use; preparations for medical purposes; substances for medical use; stem cells for medical purposes; stem cells for veterinary purposes; stem cells for aesthetic purposes; somatic stem cell therapeutics; fibroblasts for medical use; fibroblasts for aesthetic purposes; pharmaceutical implants; surgical implants derived from stem cells; surgical implants derived from fibroblasts; biological tissue for implantation; cell growth media for growing cells for medical use; pharmaceutical preparations for tissue regeneration; vascular grafts; living tissue; biotechnologically engineered tissue products. Class 42 Stem cell research; scientific and medical research and development; scientific research, testing and analysis services; scientific research for medical purposes; medical research; research and development of new products for others; consultancy in the field of pharmaceutical research; providing information on medical and scientific research on pharmaceutical products; biomedical research; preparation of reports relating to scientific research; research in the field of biotechnology; research in the field of gene therapy; research and development in the field of immunology; research and development in the field of antibodies; research and development in the field of antibody technology; research and development in the field of bacteriology; research and development in the field of gene expression systems; research and development in the field of vaccines; research and development services for the pharmaceutical industry; research and development services in the field of biotechnology; development of industrial processes; industrial process research. Class 44 Medical services relating to the removal, treatment, processing and preservation of medical cells and human tissue, stem cells and bone marrow, also in the field of regenerative medicine, including tissue engineering; medical services in connection with the removal, treatment and processing of human tissue and stem cells, human tissue and stem cell bank services, including in the field of regenerative medicine, including tissue engineering; medical services relating to the cultivation and extraction of stem cells; medical services in connection with the cultivation and extraction of stem cells. |
| (540) |
|
| (550) | Figurative |
| (730) |
Dr. Christoph Ganss
|
Find out more about publications on the About page.